281 related articles for article (PubMed ID: 29128259)
1. Role of Dysregulated Cytokine Signaling and Bacterial Triggers in the Pathogenesis of Cutaneous T-Cell Lymphoma.
Fanok MH; Sun A; Fogli LK; Narendran V; Eckstein M; Kannan K; Dolgalev I; Lazaris C; Heguy A; Laird ME; Sundrud MS; Liu C; Kutok J; Lacruz RS; Latkowski JA; Aifantis I; Ødum N; Hymes KB; Goel S; Koralov SB
J Invest Dermatol; 2018 May; 138(5):1116-1125. PubMed ID: 29128259
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
3. Is there a role for epigenetic factors in the pathogenesis of epidermotropic cutaneous T-cell lymphomas (mycosis fungoides and Sézary syndrome)?
Bachelez H
Hematol J; 2001; 2(4):286-9. PubMed ID: 11920262
[No Abstract] [Full Text] [Related]
4. Malignant cutaneous T-cell lymphoma cells express IL-17 utilizing the Jak3/Stat3 signaling pathway.
Krejsgaard T; Ralfkiaer U; Clasen-Linde E; Eriksen KW; Kopp KL; Bonefeld CM; Geisler C; Dabelsteen S; Wasik MA; Ralfkiaer E; Woetmann A; Odum N
J Invest Dermatol; 2011 Jun; 131(6):1331-8. PubMed ID: 21346774
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathogenesis of cutaneous lymphomas.
Stadler R; Stranzenbach R
Exp Dermatol; 2018 Oct; 27(10):1078-1083. PubMed ID: 29862563
[TBL] [Abstract][Full Text] [Related]
6. New Molecular and Biological Markers in Cutaneous T Cell Lymphoma: Therapeutic Implications.
Luna DE; Shinohara MM
Curr Hematol Malig Rep; 2023 Jun; 18(3):83-88. PubMed ID: 37017872
[TBL] [Abstract][Full Text] [Related]
7. A Microbiota-Dependent, STAT3-Driven Mouse Model of Cutaneous T-Cell Lymphoma.
Wu X; Hwang ST
J Invest Dermatol; 2018 May; 138(5):1022-1026. PubMed ID: 29681389
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways.
Patil K; Kuttikrishnan S; Khan AQ; Ahmad F; Alam M; Buddenkotte J; Ahmad A; Steinhoff M; Uddin S
Semin Cancer Biol; 2022 Nov; 86(Pt 3):382-399. PubMed ID: 34906723
[TBL] [Abstract][Full Text] [Related]
9. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
Zhang Q; Nowak I; Vonderheid EC; Rook AH; Kadin ME; Nowell PC; Shaw LM; Wasik MA
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9148-53. PubMed ID: 8799169
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous T-cell lymphoma: molecular genetics, immunology and pathogenesis.
Reinhold U; Abken H
Eur J Cancer; 1995; 31A(5):793-9. PubMed ID: 7640056
[No Abstract] [Full Text] [Related]
11. Immunopathogenesis of mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma).
Wong HK
G Ital Dermatol Venereol; 2008 Dec; 143(6):375-83. PubMed ID: 19169210
[TBL] [Abstract][Full Text] [Related]
12. Single-Cell RNA Sequencing Unveils the Clonal and Transcriptional Landscape of Cutaneous T-Cell Lymphomas.
Gaydosik AM; Stonesifer CJ; Khaleel AE; Geskin LJ; Fuschiotti P
Clin Cancer Res; 2022 Jun; 28(12):2610-2622. PubMed ID: 35421230
[TBL] [Abstract][Full Text] [Related]
13. Understanding Cell Lines, Patient-Derived Xenograft and Genetically Engineered Mouse Models Used to Study Cutaneous T-Cell Lymphoma.
Gill RPK; Gantchev J; Martínez Villarreal A; Ramchatesingh B; Netchiporouk E; Akilov OE; Ødum N; Gniadecki R; Koralov SB; Litvinov IV
Cells; 2022 Feb; 11(4):. PubMed ID: 35203244
[TBL] [Abstract][Full Text] [Related]
14. Clonotypic Diversity of the T-cell Receptor Corroborates the Immature Precursor Origin of Cutaneous T-cell Lymphoma.
Hamrouni A; Fogh H; Zak Z; Ødum N; Gniadecki R
Clin Cancer Res; 2019 May; 25(10):3104-3114. PubMed ID: 30808775
[TBL] [Abstract][Full Text] [Related]
15. An Integrated Data Resource for Genomic Analysis of Cutaneous T-Cell Lymphoma.
Chang LW; Patrone CC; Yang W; Rabionet R; Gallardo F; Espinet B; Sharma MK; Girardi M; Tensen CP; Vermeer M; Geskin LJ
J Invest Dermatol; 2018 Dec; 138(12):2681-2683. PubMed ID: 29981755
[No Abstract] [Full Text] [Related]
16. Overview of Cutaneous T-Cell Lymphomas.
Larocca CA; LeBoeuf NR
Hematol Oncol Clin North Am; 2019 Aug; 33(4):669-686. PubMed ID: 31229162
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of cutaneous lymphomas.
Dummer R; Willers J; Kamarashev J; Urosevic M; Döbbeling U; Burg G
Semin Cutan Med Surg; 2000 Jun; 19(2):78-86. PubMed ID: 10892708
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.
Wang L; Rocas D; Dalle S; Sako N; Pelletier L; Martin N; Dupuy A; Tazi N; Balme B; Vergier B; Beylot-Barry M; Carlotti A; Bagot M; Battistella M; Chaby G; Ingen-Housz-Oro S; Gaulard P; Ortonne N
Br J Dermatol; 2022 Dec; 187(6):970-980. PubMed ID: 35895386
[TBL] [Abstract][Full Text] [Related]
19. Insights Into the Molecular and Cellular Underpinnings of Cutaneous T Cell Lymphoma.
Yumeen S; Girardi M
Yale J Biol Med; 2020 Mar; 93(1):111-121. PubMed ID: 32226341
[TBL] [Abstract][Full Text] [Related]
20. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
